Of Super Tuesday and Superconductivity

Campaign ‘88 has now passed through the Straits of Super Tuesday. Not all candidates passed in safety. Republican George Bush swamped his opponents, while among the Democrats the field was narrowed considerably, with Michael Dukakis, Albert Gore and Jesse Jackson the apparent survivors. Whoever the eventual nominees for the two parties, the pair should focus their debates, at least in some part, on ways to ensure the effective use of our scientific assets. In our last issue we ran a p

Written byEugene Garfield
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Campaign ‘88 has now passed through the Straits of Super Tuesday. Not all candidates passed in safety.

Republican George Bush swamped his opponents, while among the Democrats the field was narrowed considerably, with Michael Dukakis, Albert Gore and Jesse Jackson the apparent survivors. Whoever the eventual nominees for the two parties, the pair should focus their debates, at least in some part, on ways to ensure the effective use of our scientific assets. In our last issue we ran a profile of the candidates’ positions on science issues (THE SCIENTIST, March 7, 1988, p. 8-9). Edwin Diamond and Norman Sandler conducted a similar survey recently in Issues in Science and Technology (“Panning for Issues in Campaign ‘88,” volume IV, no. 2, Winter 1988, p. 60-69).

Reading the statements of the candidates and listening to their speeches makes one hunger for more substance, more precision. For example, how do they propose ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies